Franklin M Berger Kezar Life Sciences, Inc. (KZR) insider trading activity

Franklin M Berger is of Kezar Life Sciences, Inc.. Currently has a direct ownership of 890,691 shares of KZR, which is worth approximately $6.79 Million. The most recent transaction as insider was on Mar 21, 2022, when has been sold 20,000 shares (Common Stock) at a price of $14.77 per share, resulting in proceeds of $295,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 891K

0% 3M change

0% 12M change

Total Value Held $6.79 Million

FRANKLIN M BERGER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 21 2022	BUY Open market or private purchase	$295,400 $14.77 p/Share	20,000 Added 2.2%	890,691 Common Stock
Mar 18 2022	BUY Open market or private purchase	$988,800 $16.48 p/Share	60,000 Added 6.45%	870,691 Common Stock
Sep 22 2021	BUY Exercise of conversion of derivative security	$49,818 $5.6 p/Share	8,896 Added 1.09%	810,691 Common Stock
Sep 21 2021	BUY Exercise of conversion of derivative security	$120,452 $6.77 p/Share	17,792 Added 2.17%	801,795 Common Stock

Also insider at

AVIR

Atea Pharmaceuticals, Inc. Healthcare

EPIX

ESSA Pharma Inc. Healthcare

FPRX

FIVE PRIME THERAPEUTICS, INC.

Director

RAIN

Rain Therapeutics Inc. Healthcare

Director

BCEL

Atreca, Inc. Healthcare

Director

FMB